Spray Otrivin

Nasal Spray Otrivin is intended for topical use in the treatment of ENT diseases. In addition to the spray, drops are produced for the nose of Otrivin for children and adults. The main active substance in the drug Otrivin is xylometazoline hydrochloride, which has a local vasoconstrictive effect. In addition, the composition of the drug includes a number of auxiliary components that vary quantitatively depending on the form and age of the agent.

Form release spray

Aerosol Otrivin is produced in the following forms:

Pharmacodynamics of the preparation

Xylometazoline hydrochloride causes narrowing of the vessels of the nasal mucosa, eliminates hyperemia and edema in the nasopharynx, thus facilitating respiration in rhinitis. Included in the drug sorbitol and hypromellosis reduce irritation and eliminate the dryness of the epithelium of the nasal mucosa. At the same time, Otrivin facilitates the separation of mucus from the nasal cavity.

The beginning of the drug - 2-5 minutes after use.

The validity period is 12 hours.

Frequency of application - 1-2 times a day.

The duration of therapy is no more than 10 days.

Indications and contraindications for use

Spray Otrivin is actively used in the treatment of acute and chronic forms of rhinitis, as well as diseases such as:

Contraindications for use are:

Only after consultation with the attending physician Otrivin can be used in the treatment of children under 2 years of age and pregnant women.

Spray analogues Otrivin

The pharmaceutical industry produces a number of structural analogues of the Otrivin spray, the active substance in which is also xylometazoline hydrochloride. Among the most popular are: